Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation

Manish Khanolkar, R.H. Morris, Andrew W. Thomas, Hemanth Bolusani, Annette Roberts, John Geen, Marc Evans

Atherosclerosis · 2007 · 46 citations · 27 references

Concepts

References

27